Evogene
EVGN
17 hedge funds and large institutions have $54.6M invested in Evogene in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
6% more funds holding
Funds holding: 16 → 17 (+1)
5% more capital invested
Capital invested by funds: $52.2M → $54.6M (+$2.38M)
0.1% more ownership
Funds ownership: 2.34% → 2.44% (+0.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$1.56M |
| 2 |
JP Morgan Chase
New York
|
+$430K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$413K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$94.9K |
| 5 |
Barclays
London,
United Kingdom
|
+$26.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$46K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.94K |
EVGN Hedge Fund Activity: Q2 2015 in Review
17 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q2 2015, worth a combined $54.6M — up 4.6% from $52.2M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new EVGN positions and 0 closed out — a net gain of 1 holder — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Waddell & Reed Financial, adding an estimated $1.56M. The largest seller was Wellington Management Group, cutting an estimated $46K.
- 17 institutional investors held Evogene (EVGN) as of Q2 2015, up from 16 in Q1 2015.
- Funds reported $54.6M of Evogene stock for Q2 2015, up 4.6% quarter-over-quarter.
- 1 fund opened new Evogene positions in Q2 2015 and 0 closed out, a net change of +1 holder.
- The largest Evogene buyer in Q2 2015 was Waddell & Reed Financial, an estimated $1.56M added.
- The largest Evogene seller in Q2 2015 was Wellington Management Group, an estimated $46K sold.
Based on aggregated 13F filings for Q2 2015.